Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph-positive Acute Lymphoblastic Leukemia

NCT04554459 is registered in ClinicalTrials.gov with Institute of Hematology and Blood Transfusion, Czech Republic as lead sponsor.

NCT NCT04554459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04554459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph-positive Acute Lymphoblastic Leukemia
Lead sponsor
Institute of Hematology and Blood Transfusion, Czech Republic
Phase
Phase 2
Overall status
Terminated
Start date
February 16, 2021
Completion date
July 1, 2024
Enrollment
4 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, adult, newly diagnosed, ph+ all